Journals / Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi / 2020 / Cilt: 34 - Sayı: 3

Effects of Taurine on the Levels of PPARγ, IRS-1, HSP-27, HSP-72 and Histopathological Changes in Kidney of the Diabetic Rats

Diyabetik Ratlarda Taurinin Böbrek Dokusunda PPARγ, IRS–1, HSP–27, HSP–72 Düzeyleri ile Histopatolojik Değişimler Üzerine Etkisi

Pages
139–145
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After 8 weeks of the study, the Taurine group was found to be statistically indifferent to the control group in terms of PPAR-γ, IRS-1, HSP-27, and HSP-72 levels (P>0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The objective of this study was to investigate the effects of taurine on PPAR-γ, IRS-1, HSP-27, and HSP-72 levels along with the kidney histopathological changes in streptozotocin (STZ) induced diabetic rats.
📊
Key Findings & Data:In the study, 40 Wistar albino male rats were divided into four groups. (i) Control group, (ii) Taurine, rats received taurine with drinking water (2%); (iii) STZ, rats were injected with STZ (60 mg/kg i.p. as single dose) and (iv) STZ+Taurine, rats received taurine and injected with STZ.
💡
Conclusion & Impact:After 8 weeks of the study, the Taurine group was found to be statistically indifferent to the control group in terms of PPAR-γ, IRS-1, HSP-27, and HSP-72 levels (P>0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The objective of this study was to investigate the effects of taurine on PPAR-γ, IRS-1, HSP-27, and HSP-72 levels along with the kidney histopathological changes in streptozotocin (STZ) induced diabetic rats. In the study, 40 Wistar albino male rats were divided into four groups. (i) Control group, (ii) Taurine, rats received taurine with drinking water (2%); (iii) STZ, rats were injected with STZ (60 mg/kg i.p. as single dose) and (iv) STZ+Taurine, rats received taurine and injected with STZ. After 8 weeks of the study, the Taurine group was found to be statistically indifferent to the control group in terms of PPAR-γ, IRS-1, HSP-27, and HSP-72 levels (P>0.05). However, PPAR-γ (P

Özet

Bu çalışmada, streptozotosin (STZ) ile diyabet oluşturulan ratlarda böbrek dokusu PPAR-γ, IRS-1,HSP-27, HSP-72 proteinlerinin düzeyleri ile böbrek histopatolojisi üzerine taurinin etkileri araştırıldı.Çalışmada, 8 haftalık, toplam 40 adet erkek Wistar albino rat 4 gruba ayrıldı: (i) Kontrol, (ii) Taurin;içme suyuna %2 taurin eklenen ratlar, (iii) STZ; 60 mg/kg dozunda STZ (i.p. tek doz) uygulananratlar, (iv) STZ+Taurin; taurin verilen ve STZ uygulanan ratlar. Sekiz haftalık çalışma sonundataurin grubu PPAR-γ, IRS-1, HSP-27 ve HSP-72 (P>0.05) düzeylerinde kontrol grubuna göreanlamlı bir değişim gözlenmezken, STZ grubu PPAR-γ (P

🔖

Cite This Article

TUZCU, M., ERTEN, F., GENÇOĞLU, H. (2022). Effects of Taurine on the Levels of PPARγ, IRS-1, HSP-27, HSP-72 and Histopathological Changes in Kidney of the Diabetic Rats. Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi, Cilt: 34 - Sayı: 3, 139–145. https://ajindex.com/articles/514889

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14
  2. Sahin K, Onderci M, Tuzcu M, et al. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat, Metabolisim 2007; 56: 1233-1240
  3. Kumar V, Cotran R, Robbins SL. Temel Patoloji. Çevikbaş U (Çeviren)
  4. Baskı, İstanbul: Nobel Tıp Kitapevi, 2000
  5. Wei T, Shu Q, Ning J, et al. The protective effect of basic fibroblast growth factor on diabetic nephropathy through remodeling metabolic phenotype and suppressing oxidative stress in mice. Front Pharmacol 2020; 11: 66
  6. Phillips AO. Diabetic nephropathy. Medicine 2011; 39: 470-474
  7. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000; 49: 27-29
  8. Maritim AC, Sanders RA, Watkins IIIJB. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2002; 17: 24-38
  9. Maleki V, Mahdavi R, Hajizadeh-Sharafabad F, Alizadeh M. The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Diabetol Metab Syndr 2020; 12: 9
  10. Kanwar YS, Wada J, Sun L, et al. Diabetic nephropathy: Mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008; 233: 4-11
  11. Luo ZF, Feng B, Mu J, et al. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: Regulation of endoplasmic reticulum stress-oxidative activation. Toxicol Appl Pharmacol 2010; 246: 49-57
  12. Kim SJ, Gupta RC, Lee HW. Taurine-diabetes interaction: From involvement to protection. J Biol Regul Homeost Agents 2007; 21: 63-77
  13. Szymanski K, Winiarska K. Taurine and its potential therapeutic application. Postepy Hig Med Dosw (Online) 2008; 62: 75-86
  14. Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla, J. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie 2009; 91: 261-270
  15. De la Puerta C, Arrieta FJ, Balsa JA, et al. Taurine and glucose metabolism: A review. Nutr Hosp 2010; 25: 910- 919
  16. Yao HT, Lin P, Chang YW, et al. Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocininduced diabetes. Food Chem Toxicol 2009; 47: 1703- 1709
  17. Farombi EO, Shrotriya S, Na HK, Kim SH